Pfizer tests drug interaction in healthy volunteers

NCT ID NCT07575945

Not yet recruiting Knowledge-focused Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen May 13, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This study checks if the antifungal itraconazole changes how the body handles a new experimental drug (PF-08642534). Healthy adults aged 18-65 will take the study drug alone and then with itraconazole. Researchers will measure drug levels and watch for side effects. The goal is to understand drug interactions, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Haven Clinical Research Unit

    New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.